Flavopiridol reduces the impedance of neural prostheses in vivo without affecting recording quality

We hypothesized that re-entry into the cell cycle may be associated with reactive gliosis surrounding neural prostheses, and that administration of a cell cycle inhibitor (flavopiridol) at the time of surgery would reduce this effect. We investigated the effects of flavopiridol on recording quality and impedance over a 28-day time period and conducted histology at 3 and 28 days post-implantation. Flavopiridol reduced the expression of a cell cycle protein (cyclin D1) in microglia surrounding probes at the 3-day time point. Impedance at 1 kHz was decreased by drug administration across the study period compared to vehicle controls. Correlations between recording (SNR, units) and impedance metrics revealed a small, but statistically significant, inverse relationship between these variables. However, the relationship between impedance and recording quality was not sufficiently strong for flavopiridol to result in an improvement in SNR or the number of units detected. Our data indicate that flavopiridol is an effective, easily administered treatment for reducing impedance in vivo, potentially through inhibiting microglial encapsulation of implanted devices. This strategy may be useful in stimulation applications, where reduced impedance is desirable for achieving activation thresholds and prolonging the lifetime of the implanted power supply. While improvements in recording quality were not observed, a combination of flavopiridol with a second strategy which enhances neuronal signal detection may enhance these results in future studies.

[1]  S. Retterer,et al.  Dexamethasone treatment reduces astroglia responses to inserted neuroprosthetic devices in rat neocortex , 2005, Experimental Neurology.

[2]  Farid Ahmed,et al.  Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Kipke,et al.  Long-term neural recording characteristics of wire microelectrode arrays implanted in cerebral cortex. , 1999, Brain research. Brain research protocols.

[4]  C. McIntyre,et al.  Tissue and electrode capacitance reduce neural activation volumes during deep brain stimulation , 2005, Clinical Neurophysiology.

[5]  Kenneth W. Horch,et al.  Neuroprosthetics theory and practice , 2004 .

[6]  C. Swanton.  Cell-cycle targeted therapies. , 2004, The Lancet. Oncology.

[7]  K. Wise,et al.  Performance of planar multisite microprobes in recording extracellular single-unit intracortical activity , 1988, IEEE Transactions on Biomedical Engineering.

[8]  W. Ondo,et al.  Predictors of battery life for the Activa Soletra 7426 Neurostimulator. , 2007, Parkinsonism & related disorders.

[9]  Patrick A Tresco,et al.  Chronic response of adult rat brain tissue to implants anchored to the skull. , 2004, Biomaterials.

[10]  S. Retterer,et al.  Controlling cellular reactive responses around neural prosthetic devices using peripheral and local intervention strategies , 2003, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[11]  W. Shain,et al.  Three-dimensional hydrogel cultures for modeling changes in tissue impedance around microfabricated neural probes , 2007, Journal of neural engineering.

[12]  Christine Haberler,et al.  No tissue damage by chronic deep brain stimulation in Parkinson's disease , 2000, Annals of neurology.

[13]  D. Szarowski,et al.  Cerebral Astrocyte Response to Micromachined Silicon Implants , 1999, Experimental Neurology.

[14]  J Miller,et al.  Minocycline increases quality and longevity of chronic neural recordings , 2007, Journal of neural engineering.

[15]  Daryl R Kipke,et al.  Complex impedance spectroscopy for monitoring tissue responses to inserted neural implants , 2007, Journal of neural engineering.

[16]  Peter E. Konrad,et al.  Postmortem analysis following 71 months of deep brain stimulation of the subthalamic nucleus for Parkinson disease. , 2008, Journal of neurosurgery.

[17]  J.P. Donoghue,et al.  Reliability of signals from a chronically implanted, silicon-based electrode array in non-human primate primary motor cortex , 2005, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[18]  Andrew B. Schwartz,et al.  Brain-Controlled Interfaces: Movement Restoration with Neural Prosthetics , 2006, Neuron.

[19]  K A Schafer,et al.  The Cell Cycle: A Review , 1998, Veterinary pathology.

[20]  C. McIntyre,et al.  Sources and effects of electrode impedance during deep brain stimulation , 2006, Clinical Neurophysiology.

[21]  S. Di Giovanni,et al.  Cell cycle activation contributes to post-mitotic cell death and secondary damage after spinal cord injury. , 2007, Brain : a journal of neurology.

[22]  S. Cogan.  Neural stimulation and recording electrodes. , 2008, Annual review of biomedical engineering.

[23]  Anni Wang,et al.  Characteristics and functions of NG2 cells in normal brain and neuropathology , 2009, Neurological research.

[24]  S. Nagarajan,et al.  THE THEORY OF CENTRAL NERVOUS SYSTEM RECORDING , 2004 .

[25]  X Liu,et al.  Stability of the interface between neural tissue and chronically implanted intracortical microelectrodes. , 1999, IEEE transactions on rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society.

[26]  Patrick A. Tresco,et al.  Impedance characterization of microarray recording electrodes in vitro , 2005, IEEE Transactions on Biomedical Engineering.

[27]  David C. Martin,et al.  Chronic neural recordings using silicon microelectrode arrays electrochemically deposited with a poly(3,4-ethylenedioxythiophene) (PEDOT) film , 2006, Journal of neural engineering.

[28]  M. Pallàs,et al.  Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons , 2007, Neuroscience.

[29]  Michael J. Black,et al.  Assistive technology and robotic control using motor cortex ensemble‐based neural interface systems in humans with tetraplegia , 2007, The Journal of physiology.

[30]  A. Lozano,et al.  Longevity of Batteries in Internal Pulse Generators Used for Deep Brain Stimulation , 2004, Stereotactic and Functional Neurosurgery.

[31]  David S. Park,et al.  Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia , 2008, Journal of neurochemistry.

[32]  Jerald D. Kralik,et al.  Chronic, multisite, multielectrode recordings in macaque monkeys , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Jon A. Mukand,et al.  Neuronal ensemble control of prosthetic devices by a human with tetraplegia , 2006, Nature.

[34]  E. Eisenhauer,et al.  A Phase II Study of Flavopiridol in Patients With Previously Untreated Advanced Soft Tissue Sarcoma , 2006, Sarcoma.

[35]  David C. Martin,et al.  Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. , 2006, Biomaterials.

[36]  P. Poindron,et al.  Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons. , 2006, Life sciences.

[37]  P. Tresco,et al.  Response of brain tissue to chronically implanted neural electrodes , 2005, Journal of Neuroscience Methods.

[38]  D.B. McCreery,et al.  Evaluation of the stability of intracortical microelectrode arrays , 2006, IEEE Transactions on Neural Systems and Rehabilitation Engineering.

[39]  Justin C. Williams,et al.  Chronic neural recording using silicon-substrate microelectrode arrays implanted in cerebral cortex , 2004, IEEE Transactions on Biomedical Engineering.

[40]  D. Kipke,et al.  Neural probe design for reduced tissue encapsulation in CNS. , 2007, Biomaterials.

[41]  M. Pallàs,et al.  Inhibition of Cell Cycle Pathway by Flavopiridol Promotes Survival of Cerebellar Granule Cells after an Excitotoxic Treatment , 2004, Journal of Pharmacology and Experimental Therapeutics.

[42]  R. Lockshin,et al.  Cell death in health and disease , 2007, Journal of cellular and molecular medicine.

[43]  E K Purcell,et al.  In vivo evaluation of a neural stem cell-seeded prosthesis , 2009, Journal of neural engineering.

[44]  N A Fitzsimmons,et al.  Primate Reaching Cued by Multichannel Spatiotemporal Cortical Microstimulation , 2007, The Journal of Neuroscience.

[45]  Kip A Ludwig,et al.  Using a common average reference to improve cortical neuron recordings from microelectrode arrays. , 2009, Journal of neurophysiology.

[46]  D. Szarowski,et al.  Brain responses to micro-machined silicon devices , 2003, Brain Research.

[47]  R. Normann,et al.  Chronic recording capability of the Utah Intracortical Electrode Array in cat sensory cortex , 1998, Journal of Neuroscience Methods.

[48]  Andrew S. Whitford,et al.  Cortical control of a prosthetic arm for self-feeding , 2008, Nature.

[49]  David M. Santucci,et al.  Learning to Control a Brain–Machine Interface for Reaching and Grasping by Primates , 2003, PLoS biology.

[50]  Ravi V. Bellamkonda,et al.  Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes , 2007, Brain Research.

[51]  D. Edell,et al.  Factors influencing the biocompatibility of insertable silicon microshafts in cerebral cortex , 1992, IEEE Transactions on Biomedical Engineering.

[52]  B. Stoica,et al.  Role of the Cell Cycle in the Pathobiology of Central Nervous System Trauma , 2005, Cell cycle.

[53]  David C. Martin,et al.  Neuronal cell loss accompanies the brain tissue response to chronically implanted silicon microelectrode arrays , 2005, Experimental Neurology.